Weimin Zhang

8PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)BiomaterialsCancer diagnosisPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 21, 2026
Chidamide synergizes with cisplatin-etoposide to trigger pyroptosis and anti-tumor immunity in diffuse large B-cell lymphoma.

|Mar 24, 2026
Halofuginone is a Molecular Glue Degrader of Integrin β4.

Wei Gong, Di Yang, Junrui Tian

|Feb 19, 2026
The consensus molecular subtypes of esophageal squamous cell carcinoma.

Heyang Cui, Zhongxu Zhu, Enwei Xu

|Dec 18, 2025
IRF2BPL transcriptionally regulates IGFBP2 to promote tumor progression and suppresses immune cell infiltration in esophageal squamous cell carcinoma.

Yueguang Wu, Heyang Cui, Longlong Wang

|May 03, 2025
Harnessing the FGFR2/NF2/YAP signaling-dependent necroptosis to develop an FGFR2/IL-8 dual blockade therapeutic strategy.

Dongshao Chen, Zitong Zhao, Ruoxi Hong

|Nov 21, 2023
IGH repertoire analysis at scale: deciphering the complexity of B cell infiltration and migration in esophageal squamous cell carcinoma.

Longlong Wang, Yong Zhou, Heyang Cui

Pageof 2

Frequent Collaborators

4 joint publications

Qimin Zhan

2 joint publications

Longlong Wang

2 joint publications

Yongping Cui

1 joint publications

Xinghua Pan